Clinical Trial: Atropine in the Treatment of Myopia Study in Malaysia

U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329777) titled 'Atropine in the Treatment of Myopia Study in Malaysia' on Sept. 16, 2025.

Brief Summary: This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.

Study Start Date: Sept. 17, 2025

Study Type: INTERVENTIONAL

Condition: Myopia Progression

Intervention: DRUG: Low dose atropine sulfate eye drops

Atropine Sulphate 0.025% w/v Eye Drops

DRUG: Placebo

Placebo

Recruitment Status: RECRUITING

Sponsor: IDB VisionCare SDN BHD

Disclaimer: Curated by HT Syndi...